Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study (Q77130683)
Jump to navigation
Jump to search
scientific article published on 01 September 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study |
scientific article published on 01 September 1996 |
Statements
Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study (English)
A Pelc
H Portier
P Gehanno
S Fiessinger
1 September 1996
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference